Magnus Schou Selected Research

Magnus Schou Research Topics

Disease

6	Neoplasms (Cancer) 02/2024 - 01/2020
5	Brain Neoplasms (Brain Tumor) 11/2023 - 01/2020
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 01/2020
3	Alzheimer Disease (Alzheimer's Disease) 01/2016 - 03/2012
2	Ataxia Telangiectasia (Louis Bar Syndrome) 02/2024 - 12/2021
2	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2021
2	Migraine Disorders (Migraine) 01/2020 - 01/2019
2	Epilepsy (Aura) 01/2020 - 01/2020
2	Parkinson Disease (Parkinson's Disease) 01/2020 - 01/2020
2	Central Nervous System Diseases (CNS Diseases) 01/2020 - 01/2018
1	Glioma (Gliomas) 11/2023
1	Sarcoma (Soft Tissue Sarcoma) 01/2023
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022
1	Synucleinopathies 01/2022
1	Glioblastoma (Glioblastoma Multiforme) 12/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Multiple System Atrophy 12/2020
1	Dementia (Dementias) 12/2020
1	Proteostasis Deficiencies 12/2020
1	Autistic Disorder (Autism) 01/2020
1	Type 2 Diabetes Mellitus (MODY) 12/2018
1	Mental Disorders (Mental Disorder) 11/2017
1	Cognitive Dysfunction 01/2016
1	Neuralgia (Stump Neuralgia) 04/2013
1	Prodromal Symptoms 04/2013
1	Amyloid Plaque 07/2012
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 09/2006

Drug/Important Bio-Agent (IBA)

3	Tyrosine Kinase InhibitorsIBA 01/2023 - 01/2020
3	osimertinibIBA 01/2023 - 01/2020
2	AZD1390IBA 02/2024 - 12/2021
2	ErbB Receptors (EGF Receptor)IBA 01/2023 - 01/2020
2	Serotonin (5 Hydroxytryptamine)IBA 01/2022 - 01/2016
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2022 - 11/2017
2	5-HT1B Serotonin ReceptorIBA 01/2019 - 01/2016
2	Amyloid (Amyloid Fibrils)IBA 04/2013 - 03/2012
1	Radiation-Sensitizing AgentsIBA 02/2024
1	Phosphotransferases (Kinase)IBA 02/2024
1	DNA (Deoxyribonucleic Acid)IBA 11/2023
1	MethyltransferasesIBA 11/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2023
1	Cysteine (L-Cysteine)FDA Link 01/2023
1	GTP Phosphohydrolases (GTPases)IBA 01/2023
1	Codon (Codons)IBA 01/2023
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2023
1	CrizotinibIBA 12/2022
1	Protein Kinases (Protein Kinase)IBA 12/2021
1	AfatinibIBA 01/2021
1	IsotopesIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Type 1 Melanocortin ReceptorIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 12/2020
1	SynucleinsIBA 12/2020
1	GangliosidesIBA 01/2020
1	Tryptophan (L-Tryptophan)FDA Link 01/2020
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2020
1	Insulin (Novolin)FDA Link 12/2018
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2018
1	N,N- dimethyl- 7- (4- (2- (pyridin- 2- yl)ethyl)piperazin- 1- yl)benzofuran- 2- carboxamideIBA 01/2016
1	benzofuranIBA 01/2016
1	2- (6- (methylamino)pyridin- 3- yl)- 1,3- benzothiazol- 6- olIBA 04/2013
1	N- (2- tert- butyl- 1- ((4,4- difluorocyclohexyl)methyl)- 1H- benzo(d)imidazol- 5- yl)ethanesulfonamideIBA 04/2013
1	AZD2995IBA 04/2013
1	LigandsIBA 07/2012
1	flutemetamolIBA 07/2012
1	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 09/2006
1	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 09/2006

Therapy/Procedure

2	Therapeutics 01/2020 - 04/2013
1	Drug Therapy (Chemotherapy) 01/2022
1	Radiotherapy 12/2021